Description
Targeting of host antiviral and immune-modulatory factors by HIV-1 Vpu: Implications for viral pathogenesis and therapy
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02016-07-01$710,985
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2016-07-01(start date) | $710,985 | — | Targeting of host antiviral and immune-modulatory factors by HIV-1 Vpu: Implications for viral pathogenesis an… |
Related records · 5
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (exact legal name match; no business number on file)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 236-2019-2020-Q1-00479 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Research in Priority Areas | $6,000,000 | FY2020 |
| 236-2017-2018-Q2-00187 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $2,470,639 | FY2018 |
| 236-2017-2018-Q1-00485 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $100,000 | FY2018 |
| 236-2016-2017-Q3-00034 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $248,700 | FY2017 |
| 236-2015-2016-Q2-00239 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $421,359 | FY2016 |
Cite as: Glassbox record view · Federal grants & contributions · 236-2016-2017-Q2-00939 · retrieved 2026-11-13.